Abgenix, Inc.
Antibody product maker files resale registration statement
Published in Healthcare Mergers, Acquisitions and Ventures Week, April 23rd, 2005
As previously announced, the notes were issued in a private placement in December 2004.
The company did not issue any new securities and will not receive any proceeds from the resale of securities under this registration statement.
The company's antibody development platform includes manufacturing capabilities that enable the rapid generation, selection and production of high affinity,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Mergers, Acquisitions and Ventures Week
More Articles from Healthcare Mergers, Acquisitions and Ventures Week
- AmeriPath, Inc.
Cancer diagnostics company reports net loss of $1.6M - American Academy of Actuaries
Social Security, Medicare reports show no financial change, actuaries conclude - American Bio Medica Corporation
Biotech company reports slight increase in net sales - American HomePatient, Inc.
Home healthcare company reports 3.1% decrease in revenue - Animas Corporation
Cygnus asset purchase consummated - Animas Technologies, LLC
Cygnus completes $10 million asset sale; stockholders approve dissolution - More from this issue of Healthcare Mergers, Acquisitions and Ventures Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
